TipRanks
Harrow Health Inc (HROW)
NASDAQ:HROW
US Market
HROW
Harrow Health
RESEARCH TOOLSreports
Want to see HROW full AI Analyst Report?

Harrow Health (HROW) Stock Forecast & Price Target

630 Followers
See the Price Targets and Ratings of:

HROW Analyst Ratings

Strong Buy
8Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
Based on 8 analysts giving stock ratings to
Harrow
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HROW Stock 12 Month Forecast

Average Price Target

$64.33
▲(55.66% Upside)
Based on 8 Wall Street analysts offering 12 month price targets for Harrow Health in the last 3 months. The average price target is $64.33 with a high forecast of $88.00 and a low forecast of $45.00. The average price target represents a 55.66% change from the last price of $41.33.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"29":"$29","44":"$44","59":"$59","74":"$74","89":"$89"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$88.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.33333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$64.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$45.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[29,44,59,74,89],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.61,35.02461538461539,39.43923076923077,43.85384615384615,48.26846153846154,52.683076923076925,57.097692307692306,61.51230769230769,65.92692307692307,70.34153846153846,74.75615384615384,79.17076923076922,83.58538461538461,{"y":88,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.61,33.20410256410256,35.798205128205126,38.39230769230769,40.98641025641025,43.580512820512816,46.17461538461538,48.76871794871795,51.362820512820505,53.956923076923076,56.55102564102563,59.1451282051282,61.739230769230765,{"y":64.33333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,30.61,31.716923076923077,32.823846153846155,33.93076923076923,35.03769230769231,36.144615384615385,37.25153846153846,38.35846153846154,39.465384615384615,40.57230769230769,41.67923076923077,42.786153846153844,43.89307692307692,{"y":45,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":48.37,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.77,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.78,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.9,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.43,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.9,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.11,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.77,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.97,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.61,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$88.00Average Price Target$64.33Lowest Price Target$45.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on HROW
Thomas Flaten
Lake Street
Lake Street
$60
Buy
45.17%
Upside
Reiterated
10/05/26
Lake Street Keeps Their Buy Rating on Harrow Health (HROW)
William Blair Analyst forecast on HROW
Lachlan Hanbury Brown
William Blair
William Blair
―
Buy
―
Reiterated
10/05/26
Analysts' Top Healthcare Picks: GE Healthcare Technologies Inc (GEHC), Harrow Health (HROW)
Craig-Hallum Analyst forecast on HROW
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
09/29/26
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)
Leerink Partners Analyst forecast on HROW
Daniel Clark
Leerink Partners
Leerink Partners
$45
Buy
8.88%
Upside
Initiated
09/09/26
Leerink bullish on Harrow, initiates with an OutperformLeerink bullish on Harrow, initiates with an Outperform
BTIG Analyst forecast on HROW
Thomas Shrader
BTIG
BTIG
$63
Buy
52.43%
Upside
Reiterated
08/25/26
Analysts' Top NA Picks: Harrow Health (HROW), Boost Run (BRUN)
H.C. Wainwright Analyst forecast on HROW
Yi Chen
H.C. Wainwright
H.C. Wainwright
$70
Buy
69.37%
Upside
Reiterated
08/12/26
Wall Street Analysts Are Bullish on Top NA Picks
Cantor Fitzgerald Analyst forecast on HROW
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$88
Buy
112.92%
Upside
Reiterated
08/10/26
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM)
B. Riley Securities Analyst forecast on HROW
Mayank Mamtani
B. Riley Securities
B. Riley Securities
$60
Buy
45.17%
Upside
Reiterated
08/10/26
B. Riley Securities Keeps Their Buy Rating on Harrow Health (HROW)
Ladenburg Thalmann & Co. Analyst forecast on HROW
Jeffrey Cohen
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$62
Buy
50.01%
Upside
Reiterated
03/04/26
Harrow price target lowered to $62 from $66 at LadenburgHarrow price target lowered to $62 from $66 at Ladenburg
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Lake Street Analyst forecast on HROW
Thomas Flaten
Lake Street
Lake Street
$60
Buy
45.17%
Upside
Reiterated
10/05/26
Lake Street Keeps Their Buy Rating on Harrow Health (HROW)
William Blair Analyst forecast on HROW
Lachlan Hanbury Brown
William Blair
William Blair
―
Buy
―
Reiterated
10/05/26
Analysts' Top Healthcare Picks: GE Healthcare Technologies Inc (GEHC), Harrow Health (HROW)
Craig-Hallum Analyst forecast on HROW
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
09/29/26
Craig-Hallum Keeps Their Buy Rating on Harrow Health (HROW)
Leerink Partners Analyst forecast on HROW
Daniel Clark
Leerink Partners
Leerink Partners
$45
Buy
8.88%
Upside
Initiated
09/09/26
Leerink bullish on Harrow, initiates with an OutperformLeerink bullish on Harrow, initiates with an Outperform
BTIG Analyst forecast on HROW
Thomas Shrader
BTIG
BTIG
$63
Buy
52.43%
Upside
Reiterated
08/25/26
Analysts' Top NA Picks: Harrow Health (HROW), Boost Run (BRUN)
H.C. Wainwright Analyst forecast on HROW
Yi Chen
H.C. Wainwright
H.C. Wainwright
$70
Buy
69.37%
Upside
Reiterated
08/12/26
Wall Street Analysts Are Bullish on Top NA Picks
Cantor Fitzgerald Analyst forecast on HROW
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$88
Buy
112.92%
Upside
Reiterated
08/10/26
Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM)
B. Riley Securities Analyst forecast on HROW
Mayank Mamtani
B. Riley Securities
B. Riley Securities
$60
Buy
45.17%
Upside
Reiterated
08/10/26
B. Riley Securities Keeps Their Buy Rating on Harrow Health (HROW)
Ladenburg Thalmann & Co. Analyst forecast on HROW
Jeffrey Cohen
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
$62
Buy
50.01%
Upside
Reiterated
03/04/26
Harrow price target lowered to $62 from $66 at LadenburgHarrow price target lowered to $62 from $66 at Ladenburg
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Harrow Health

3 Months
Chase KnickerbockerCraig-Hallum
Success Rate
16/25 ratings generated profit
64%
Average Return
+23.20%
Copying Chase Knickerbocker's trades and holding each position for 3 Months would result in 64.00% of your transactions generating a profit, with an average return of +23.20% per trade.
1 Year
Mayank MamtaniB. Riley Securities
Success Rate
12/22 ratings generated profit
55%
Average Return
+64.85%
Copying Mayank Mamtani's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +64.85% per trade.
2 Years
Mayank MamtaniB. Riley Securities
Success Rate
13/22 ratings generated profit
59%
Average Return
+79.46%
Copying Mayank Mamtani's trades and holding each position for 2 Years would result in 59.09% of your transactions generating a profit, with an average return of +79.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HROW Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
8
7
5
3
4
Buy
7
10
14
13
9
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
17
19
16
13
In the current month, HROW has received 13 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HROW average Analyst price target in the past 3 months is 64.33.
Each month's total comprises the sum of three months' worth of ratings.

HROW Financial Forecast

HROW Earnings Forecast

Next quarter’s earnings estimate for HROW is $0.19 with a range of $0.01 to $0.37. The previous quarter’s EPS was -$0.46. HROW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HROW has Performed in-line its overall industry.
Next quarter’s earnings estimate for HROW is $0.19 with a range of $0.01 to $0.37. The previous quarter’s EPS was -$0.46. HROW beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HROW has Performed in-line its overall industry.

HROW Sales Forecast

Next quarter’s sales forecast for HROW is $98.47M with a range of $94.40M to $101.70M. The previous quarter’s sales results were $70.66M. HROW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HROW has Performed in-line its overall industry.
Next quarter’s sales forecast for HROW is $98.47M with a range of $94.40M to $101.70M. The previous quarter’s sales results were $70.66M. HROW beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HROW has Performed in-line its overall industry.

HROW Stock Forecast FAQ

What is HROW’s average 12-month price target, according to analysts?
Based on analyst ratings, Harrow Health Inc’s 12-month average price target is 64.33.
    What is HROW’s upside potential, based on the analysts’ average price target?
    Harrow Health Inc has 55.66% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HROW a Buy, Sell or Hold?
          Harrow Health Inc has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Harrow Health Inc’s price target?
            The average price target for Harrow Health Inc is 64.33. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $88.00 ,the lowest forecast is $45.00. The average price target represents 55.66% Increase from the current price of $41.33.
              What do analysts say about Harrow Health Inc?
              Harrow Health Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
                How can I buy shares of HROW?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.